SLC27A2 anticorps (AA 346-405)

N° du produit ABIN1724864

Détail du produit anti-SLC27A2 anticorps

Antigène: SLC27A2 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2))

Épitope: AA 346-405

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp SLC27A2 est non-conjugé

Application: ELISA, Western Blotting (WB), Immunohistochemistry (IHC)

Purification: purified

Immunogène: Purified recombinant fragment of human SLC27A2 (AA: 346-405) expressed in E. coli.

Clone: 6B3A9

Isotype: IgG1

Information d'application

Indications d'application: ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified antibody in PBS with 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C/-20 °C

Stockage commentaire: 4°C, -20°C for long term storage

Références pour anticorps anti-SLC27A2 (ABIN1724864)

Mishima, Miner, Morizane, Stahl, Sadovsky: "The expression and function of fatty acid transport protein-2 and -4 in the murine placenta." dans: PLoS ONE, Vol. 6, Issue 10, pp. e25865, (2011) (PubMed).

Campa, Hüsing, Chang-Claude, Dostal, Boeing, Kröger, Tjønneland, Roswall, Overvad, Dahm, Rodríguez, Sala, Pérez, Larrañaga, Chirlaque, Ardanaz, Khaw, Wareham, Allen, Travis, Trichopoulou, Naska et al.: "Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). ..." dans: European journal of cancer (Oxford, England : 1990), Vol. 47, Issue 3, pp. 420-7, (2011) (PubMed).

Détails sur SLC27A2

Antigène: SLC27A2 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2))

Autre désignation: SLC27A2 (SLC27A2 Produits)

Synonymes: anticorps vlcs, anticorps fatp2, anticorps vlacs, anticorps acsvl1, anticorps facvl1, anticorps im:7139614, anticorps slc27a2, anticorps wu:fb99g05, anticorps zgc:112376, anticorps ACSVL1, anticorps FACVL1, anticorps HsT17226, anticorps hFACVL1, anticorps FATP2, anticorps VLCS, anticorps Vlac, anticorps Vlacs, anticorps VLACS, anticorps solute carrier family 27 (fatty acid transporter), member 2 L homeolog, anticorps solute carrier family 27 member 2, anticorps solute carrier family 27 (fatty acid transporter), member 2a, anticorps solute carrier family 27 (fatty acid transporter), member 2, anticorps slc27a2.L, anticorps SLC27A2, anticorps slc27a2a, anticorps slc27a2, anticorps Slc27a2

Sujet:

Description: The protein encoded by this gene is an isozyme of long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme activates long-chain, branched-chain and very-long-chain fatty acids containing 22 or more carbons to their CoA derivatives. It is expressed primarily in liver and kidney, and is present in both endoplasmic reticulum and peroxisomes, but not in mitochondria. Its decreased peroxisomal enzyme activity is in part responsible for the biochemical pathology in X-linked adrenoleukodystrophy. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. , ,

Aliases: VLCS, FATP2, VLACS, ACSVL1, FACVL1, hFACVL1, HsT17226

Poids moléculaire: 70.3 kDa

ID gène: 11001

HGNC: 11001

Pathways: Monocarboxylic Acid Catabolic Process, SARS-CoV-2 Protein Interactome